BRIEF: Bayzed Health to raise up to $115 million in Hong Kong IPO

2609.HK
111 does healthcare

Cancer hospital operator Bayzed Health Group Inc. (2609.HK) launched its Hong Kong IPO on Friday, aiming to raise up to HK$900 million ($115 million). The company said it plans to sell 133 million shares at between HK$4.22 and HK$6.75 per share, according to its announcement marking the listing’s launch.

Final pricing will take place on June 19, with trading set to begin on June 23.

Bayzed operates six self-owned hospitals around China engaged in the detection and treatment of cancer. The company reported 1.19 billion yuan ($166 million) in revenue last year, up 11% from 1.07 billion yuan in 2023. Its loss for 2024 narrowed to 13.5 million yuan from a 24.6 million yuan loss the previous year.

By Doug Young

To subscribe to Bamboo Works free weekly newsletter, click here

, ,
,

Related Articles

RELATED ARTICLES

No related posts.

Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

World Road does logistics

World Road faces bumpy path to Nasdaq listing

The cross-border logistics company has quadrupled the size of its IPO in response to new rules seeking to stamp out suspicious new Chinese listings, seeking to raise $33 million Key…
ASR looks to climb up the value chain

Volume chipmaker ASR looks to climb up the value chain

The global leader in cellular connectivity chips has filed for a Hong Kong listing as it accelerates its push into the higher-margin business of specialized ASIC chips Key Takeaways: ASR…
688220.SHG
Tinci IPO gets CSRC approval

Is Tinci Materials limping to a Hong Kong IPO?

China’s securities regulator has given the green light to the battery materials maker’s Hong Kong listing application, but only after a year of scrutiny Key Takeaways: Tinci Materials has been…
002709.SHE